136 related articles for article (PubMed ID: 3647677)
1. Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor.
Tokumura A; Yoshida J; Maruyama T; Fukuzawa K; Tsukatani H
Thromb Res; 1987 Apr; 46(1):51-63. PubMed ID: 3647677
[TBL] [Abstract][Full Text] [Related]
2. Platelet aggregation induced by ether-linked phospholipids. 2. Mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists.
Tokumura A; Yoshida J; Okasaka N; Fukuzawa K; Tsukatani H
Thromb Res; 1987 Apr; 46(1):153-61. PubMed ID: 3590110
[TBL] [Abstract][Full Text] [Related]
3. A platelet-aggregating and hypotensive phospholipid isolated from bovine brain.
Yoshida J; Tokumura A; Fukuzawa K; Terao M; Takauchi K; Tsukatani H
J Pharm Pharmacol; 1986 Dec; 38(12):878-82. PubMed ID: 2880959
[TBL] [Abstract][Full Text] [Related]
4. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
[TBL] [Abstract][Full Text] [Related]
5. [Antagonists of platelet activating factor].
Tokumura A; Tsukatani H
Seikagaku; 1985 Dec; 57(12):1618-23. PubMed ID: 3009656
[No Abstract] [Full Text] [Related]
6. Effects of CV-3988, an antagonist of platelet-activating factor (PAF), on washed rabbit platelets.
Cox CP
Thromb Res; 1986 Jan; 41(2):211-22. PubMed ID: 2421432
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of PAF-induced human platelet responses by newly synthesized ether phospholipids.
Ostermann G; Hofmann B; Kertscher HP; Till U
Thromb Res; 1991 Feb; 61(3):261-9. PubMed ID: 2028445
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid-induced aggregation of human and feline platelets: structure-activity relationship.
Tokumura A; Fukuzawa K; Isobe J; Tsukatani H
Biochem Biophys Res Commun; 1981 Mar; 99(2):391-8. PubMed ID: 6909028
[No Abstract] [Full Text] [Related]
9. Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam.
Cox CP; Wood KL
Thromb Res; 1987 Aug; 47(3):249-57. PubMed ID: 3629553
[TBL] [Abstract][Full Text] [Related]
10. Structural analogs of alkylacetylglycerophosphocholine inhibitory behavior on platelet activation.
Tokumura A; Homma H; Hanahan DJ
J Biol Chem; 1985 Oct; 260(23):12710-4. PubMed ID: 3840169
[TBL] [Abstract][Full Text] [Related]
11. CV-3988 - a specific antagonist of platelet activating factor (PAF).
Terashita Z; Tsushima S; Yoshioka Y; Nomura H; Inada Y; Nishikawa K
Life Sci; 1983 Apr; 32(17):1975-82. PubMed ID: 6403793
[TBL] [Abstract][Full Text] [Related]
12. Human platelet aggregation induced by 1-alkyl-lysophosphatidic acid and its analogs: a new group of phospholipid mediators?
Simon MF; Chap H; Douste-Blazy L
Biochem Biophys Res Commun; 1982 Oct; 108(4):1743-50. PubMed ID: 6924857
[No Abstract] [Full Text] [Related]
13. Albumin inhibits platelet-activating factor (PAF)-induced responses in platelets and macrophages: implications for the biologically active form of PAF.
Grigoriadis G; Stewart AG
Br J Pharmacol; 1992 Sep; 107(1):73-7. PubMed ID: 1330167
[TBL] [Abstract][Full Text] [Related]
14. Species difference in the specific receptors of platelet activating factor.
Hwang SB; Lam MH
Biochem Pharmacol; 1986 Dec; 35(24):4511-8. PubMed ID: 3024653
[TBL] [Abstract][Full Text] [Related]
15. Role of endogenous arachidonate metabolites in phospholipid-induced human platelet activation.
MacIntyre DE; Shaw AM; Pollock WK; Marks G; Westwick J
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():423-8. PubMed ID: 6221557
[No Abstract] [Full Text] [Related]
16. Lysophosphatidic acid can activate platelets without increasing 32P-labelling of phosphatidic acid.
Gerrard JM; Robinson P
Biochim Biophys Acta; 1984 Oct; 795(3):487-92. PubMed ID: 6433985
[TBL] [Abstract][Full Text] [Related]
17. Polymorphonuclear leukocyte-platelet interactions: acetylglyceryl ether phosphocholine-induced platelet activation under stimulation with chemotactic peptide.
Oda M; Satouchi K; Yasunaga K; Saito K
J Biochem; 1986 Nov; 100(5):1117-23. PubMed ID: 3818574
[TBL] [Abstract][Full Text] [Related]
18. Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action. Evidence against a second messenger role for lysophosphatidic acid.
Watson SP; McConnell RT; Lapetina EG
Biochem J; 1985 Nov; 232(1):61-6. PubMed ID: 3853461
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet.
Terashita Z; Imura Y; Nishikawa K
Biochem Pharmacol; 1985 May; 34(9):1491-5. PubMed ID: 2986648
[TBL] [Abstract][Full Text] [Related]
20. Specific antagonists of platelet activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver.
Buxton DB; Hanahan DJ; Olson MS
Biochem Pharmacol; 1986 Mar; 35(6):893-7. PubMed ID: 3754140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
